People living with HIV are developing age-related comorbidities more frequently and at earlier ages than the general population. Alongside this rise in multimorbidity is an increase in polypharmacy: a special challenge especially for older people living with HIV, placing them at high risk for drug–drug interactions (DDIs) potentially leading to poor clinical outcomes including physical decline, cognitive impairment, falls, hospitalisations, and increased mortality.
This is a RACGP CPD module with an allocated 1 hour of Education Activities (EA), 8 hours of Measuring Outcomes (MO), and 2 hours of Reflective Practice (RP) under the RACGP 2026-28 CPD program.
Learning Objectives:
- Evaluate the gaps between your practice and recommendations from recognised sources of guidance in the area of drug-drug interactions
- Determine appropriate regular medication review strategies to provide optimisation of therapy in people living with HIV.
- Determine appropriate deprescribing strategies to provide optimisation of therapy in people living with HIV.
- Identify suitable resources for people living with HIV to enhance their ability to understand the implications of drug-drug interactions.
- Review changes that are required to improve the quality of care for people living with HIV in your practice.
This audit program was developed by Lateral Connections at the request of, and with funding from, ViiV Healthcare Australia.
691d256059025-bpthumb.png){kind=avatar}